TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event

KB Home (KBH)

Consumer Cyclical Residential Construction
56.30 $
+2.4% vs. previous close
Closing price · As of: 3. Aug 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at KB Home.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 11 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Trading Day

Previous Close
55.00$
Open
56.30$
Day High
57.30$
Day Low
55.20$
Volume
1,312,219shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
45.00 $ 68.00 $
05/19/2026 09/05/2025

Current price 56.30 $ — 49% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
3.5$B
Shares Outstanding
61Mio.
Float
95.3%
Beta
1.3

Performance

Perf. 1M
27.40%
Perf. 3M
23.70%
Perf. 6M
10.10%
YTD Performance (%)
-5.70%
52-Week-High Distance
-11.6%
Perf. 1Y
0.15%
Perf. 3Y
10.37%
Perf. 5Y
42.48%
Perf. 10Y
306.82%
Perf. Since Inception
2,533.11%

Technical Indicators

MA 38 Days
56.60$
MA 50 Days
55.10$
MA 200 Days
57.20$
RSI (14)
50.0
Volatility 30 Days
55.4%
Volatility 250 Days
38.4%

Calculated from the price history · as of 08/04/2026

Valuation

P/E
14.0
Forward P/E
16.8
PEG
6.0
P/B
0.9
P/S
0.6
EV/EBITDA
14.0
Price/FCF
9.5

Profitability

Gross Margin
17.7%
EBIT Margin
3.6%
Net Margin
4.9%
Return on Equity
8.9%
Return on Assets
3.4%

Balance Sheet & Safety

Equity Ratio
66.5%
Debt/Equity
0.4
fortress balance sheet
Altman Z″
12.08
weak
Piotroski
2 out of 9

Growth

Sales Growth Last Quarter
-22.60%
EPS Growth Last Quarter
-65.00%
Sales Growth (Year)
-10.01%
Forward Sales Growth
8.20%
Forward EPS Growth
40.30%

Dividend

Dividend Yield
1.82%
Dividend Per Share (TTM)
1.00$
Payout Ratio
24.3%
Years Without a Cut
12Years
Increase Streak
3Years

Quality & Screener

Stage
4
RS Rating
27
EPS Rating
10
weak
Piotroski
2 out of 9
Fundamental Rating
D (39 out of 100)
fortress balance sheet
Altman Z″
12.08

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Growth Score

3 of 10 Weak growth

Ten checks against the annual reports — each one passed counts a point.

  • Revenue grows by more than 15% a year over three years -3.3% failed
  • More than 10% revenue growth is expected for the coming year 8.2% failed
  • Share count grows by less than 3% a year -8.1% passed
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -5.4% failed
  • Gross margin at 40% or higher and without meaningful erosion 18.8% failed
  • Goodwill from acquisitions does not grow faster than revenue 0.0% passed
  • Net debt below twice EBITDA 2.5 x EBITDA failed
  • Operating cash flow covers the profits of the last three years 107 m passed
  • Return on capital at 15% or higher, or up versus two years ago 9.8% failed
  • Insiders hold at least 10% or are net buyers 4.3% failed

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 56.30 $
Price Target (average) 58.67 $

The price target sits 4.2% above the current price.

Consensus
Hold
Analyst Ratings
16
Distribution of Recommendations
Strong Buy 1
Buy 2
Hold 10
Sell 0
Strong Sell 3

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
11/30/2026 3.33 3.19 – 3.55 5,117 -51.0% 13
11/30/2027 4.61 3.88 – 5.45 5,534 34.4% 13

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

23. Sep 2026 · Q3 2026
Expected Earnings per Share
0.88 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 1,999.9 $M Q4 2025: Q1 · 1,391.8 $M Q1 2025: Q2 · 1,529.6 $M Q2 2025: Q3 · 1,620.5 $M Q3 2025: Q4 · 1,694.4 $M Q4 2026: Q1 · 1,077.0 $M Q1 2026: Q2 · 1,112.4 $M Q2

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 2.54 35.90 2,000 19.50 9.50 363 353
2025: Q1 1.50 -15.30 1,392 -5.20 7.90 -334 -346
2025: Q2 1.50 -30.90 1,530 -10.50 7.10 168 157
2025: Q3 1.62 -21.00 1,621 -7.50 6.80 198 186
2025: Q4 1.56 -38.50 1,694 -15.30 6.00 307 293
2026: Q1 0.52 -65.00 1,077 -22.60 3.10 -125 -139
2026: Q2 0.43 -71.30 1,112 -27.30 2.50 32 22
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 3,595 152 106 1.10 189 1,723 5,132
2017 4,369 283 181 1.84 513 1,926 5,042
2018 4,547 346 170 1.69 222 2,088 5,074
2019 4,553 331 269 2.86 251 2,383 5,015
2020 4,183 316 296 3.15 311 2,666 5,356
2021 5,725 661 565 6.03 -37 3,019 5,836
2022 6,904 1,055 817 9.14 183 3,661 6,652
2023 6,411 719 590 7.08 1,083 3,810 6,648
2024 6,930 786 655 8.51 363 4,061 6,936
2025 6,236 525 429 6.19 336 3,901 6,721

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

KB Home ist als Wohnungsbauunternehmen in den USA tätig. Es baut und verkauft Häuser, darunter angebaute und freistehende Einfamilienhäuser, Stadthäuser und Eigentumswohnungen, hauptsächlich für Erstkäufer, erste und zweite Aufsteiger sowie aktive Senioren.

CEO Insider Trades (12 Mo.)selling own stock
Employees2,118
HeadquartersLos Angeles, CA
Address10990 Wilshire Boulevard, 90024 Los Angeles, United States
Phone310 231 4000
Websitekbhome.com
IPO Date1. Jan 1987
ISINUS48666K1097
Stock Split2:1 on 04/29/2005

Management

Management
Name Title Birth Year
Jeffrey T. Mezger Executive Chairman 1956
Robert V. McGibney CEO, President & Director 1975
Brian J. Woram J.D. Executive VP & General Counsel 1961
Albert Z. Praw J.D. Executive Vice President of Real Estate & Business Development 1949
William R. Hollinger CPA Senior VP & Chief Accounting Officer 1959
Dan Bridleman Senior Vice President of Sustainability, Technology & Strategic Sourcing
Jill S. Peters Senior Vice President of Investor Relations
Amit Desai Senior VP & Chief Marketing Officer
Thomas F. Norton Senior Vice President of Human Resources 1971
Vince DePorre Southeast Regional President

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
15. Jul 2026 Mezger Jeffrey T Executive Chairman Sell 30,008 56.70 1,701,454
15. Jul 2026 Mezger Jeffrey T Executive Chairman Sell 21,010 56.24 1,181,602
15. Jul 2026 Mezger Jeffrey T Executive Chairman Other 51,018 16.21 827,002
14. Jul 2026 Mezger Jeffrey T Executive Chairman Sell 39,204 55.45 2,173,862
14. Jul 2026 Mezger Jeffrey T Executive Chairman Sell 89,858 54.87 4,930,508
14. Jul 2026 Mezger Jeffrey T Executive Chairman Other 129,062 16.21 2,092,095
13. Jul 2026 McGibney Robert V. President and CEO Sell 20,621 55.31 1,140,548
13. Jul 2026 McGibney Robert V. President and CEO Other 20,621 16.21 334,266
13. Jul 2026 Mezger Jeffrey T Executive Chairman Sell 12,825 55.81 715,763
13. Jul 2026 Mezger Jeffrey T Executive Chairman Sell 82,047 54.95 4,508,483

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Chart

Interactive price chart (TradingView).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?